AOP Orphan Accuses PharmaEssentia Of Arbitration Fraud
AOP Orphan has asked authorities in Germany to investigate allegedly deceptive statements a Taiwanese drug developer made during arbitration over an ill-fated deal to develop a new blood cancer treatment, including...To view the full article, register now.
Already a subscriber? Click here to view full article